MedPath

NEURALSTEM INC

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

7

Active:0
Completed:2

Trial Phases

2 Phases

Phase 1:4
Phase 2:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (6 trials with phase data)โ€ข Click on a phase to view related trials

Phase 1
4 (66.7%)
Phase 2
2 (33.3%)

A Longitudinal Observational Cohort Study of NSI-189, With Out-Patients With Major Depressive Disorder

Conditions
Major Depressive Disorder
Interventions
First Posted Date
2016-03-31
Last Posted Date
2016-09-21
Lead Sponsor
Neuralstem Inc.
Target Recruit Count
220
Registration Number
NCT02724735

Study of NSI-189 for Major Depressive Disorder

Phase 2
Conditions
Major Depressive Disorder
Interventions
First Posted Date
2016-03-01
Last Posted Date
2017-02-24
Lead Sponsor
Neuralstem Inc.
Target Recruit Count
220
Registration Number
NCT02695472
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Collaborative Neuroscience Network, LLC, Garden Grove, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Synergy San Diego, National City, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Clinical Trials of the Rockies, Denver, Colorado, United States

and more 9 locations

Safety Study of Human Spinal Cord-derived Neural Stem Cell Transplantation for the Treatment of Chronic SCI

Phase 1
Conditions
Spinal Cord Injury (SCI)
Interventions
Drug: Human spinal cord stem cells.
First Posted Date
2013-01-21
Last Posted Date
2017-09-11
Lead Sponsor
Neuralstem Inc.
Target Recruit Count
8
Registration Number
NCT01772810
Locations
๐Ÿ‡บ๐Ÿ‡ธ

UCSD Medical Center, Division of Neurosurgery, San Diego, California, United States

Dose Escalation and Safety Study of Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis

Phase 2
Conditions
Amyotrophic Lateral Sclerosis
First Posted Date
2012-11-21
Last Posted Date
2015-04-20
Lead Sponsor
Neuralstem Inc.
Target Recruit Count
18
Registration Number
NCT01730716
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Emory University, Atlanta, Georgia, United States

๐Ÿ‡บ๐Ÿ‡ธ

Massachusetts General Hospital, Boston, Massachusetts, United States

๐Ÿ‡บ๐Ÿ‡ธ

University of Michigan, Ann Arbor, Michigan, United States

Multiple-Dose Pharmacokinetics (PK), and Pharmacodynamic (PD) Effect of NSI-189 Phosphate in Depression Patient Subjects

Phase 1
Completed
Conditions
Depression
Interventions
First Posted Date
2012-01-30
Last Posted Date
2014-04-02
Lead Sponsor
Neuralstem Inc.
Target Recruit Count
26
Registration Number
NCT01520649
Locations
๐Ÿ‡บ๐Ÿ‡ธ

California Clinical Trials, Glendale, California, United States

  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

ยฉ 2025 MedPath, Inc. All rights reserved.